Chinese pharmaceutical company Chengdu Easton Biopharmaceuticals Co Ltd plans to raise 1.3 billion yuan ($193 million) in an initial public offering (IPO) on the Nasdaq-style STAR Market of the Shanghai Stock Exchange, according to a company filing.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
